Apogem Capital: $1.43 Billion Raised For Seventh Secondary Fund Focused On Middle Market Transactions

By Amit Chowdhry • Mar 31, 2026

Apogem Capital, a private markets investment firm and subsidiary of New York Life Insurance Company, announced the final close of its seventh secondary fund, Apogem Secondary Fund VII, at a $1.43 billion hard cap, with total commitments exceeding $1.45 billion, including employee contributions.

The fund surpassed its $1 billion target and is more than double the size of its predecessor, reflecting strong investor demand. The capital was raised from a diverse base of institutional investors, including public and private pension plans, family offices, and registered investment advisors, alongside commitments from Apogem employees and its parent organization.

Apogem Secondary Fund VII will pursue a strategy centered on building a diversified portfolio of GP-led and LP secondary transactions across the North American middle market. The firm emphasized its longstanding focus in this segment, supported by its track record as both a sole buyer in LP secondaries and a lead or co-lead investor in GP-led deals.

The fund is part of Apogem’s broader platform, which manages approximately $44 billion in assets across private equity and private credit strategies. The firm highlighted its ability to source deal flow through deep sponsor relationships and integration across its investment platform.

Apogem stated that demand for liquidity solutions in private markets continues to grow as the asset class evolves, positioning the firm to expand its activity in secondary transactions and customized capital solutions.

KEY QUOTES:

“We believe our focused middle market strategy, disciplined underwriting, and extensive network of private equity sponsor relationships position us well for the opportunities ahead.”

Josh Niedner, Chief Executive Officer, Apogem Capital

“We are grateful for the continued support of our longstanding investors and pleased to welcome new institutional partners to ASF VII. Our Liquidity Solutions team has spent years structuring tailored capital solutions for middle market GPs and LPs. With ASF VII, we feel well-positioned to build on our demonstrated track record and to continue delivering innovative, high-quality solutions to our partners.”

Mike Zeleniuch, Managing Director And Head Of Liquidity Solutions, Apogem Capital